Florida cancer study aims to speed up personalized treatment plans
NCT ID NCT07167381
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 25 times
Summary
This study is testing whether a new lab platform can quickly suggest personalized cancer treatments for 210 patients in Florida whose cancer has come back or not responded to standard therapy. The platform combines drug sensitivity testing and genetic profiling to recommend options. The main goal is to see if these recommendations can be delivered within two weeks to help doctors make treatment decisions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
First Ascent Biomedical
RECRUITINGMiami, Florida, 33183, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Florida International University
ACTIVE_NOT_RECRUITINGMiami, Florida, 33199, United States
Conditions
Explore the condition pages connected to this study.